menu
    • menu

    Company profile for Centessa Pharmaceuticals

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Centessa Pharmaceuticals aims to improve R&D productivity by scaling the asset centric model of a smaller company to that of a larger enterprise. In doing so, Centessa represents a new kind of pharmaceutical company that operates in a bottom-up organizational structure with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts. At its inception, Centessa consists of 10 subsi...
    Centessa Pharmaceuticals aims to improve R&D productivity by scaling the asset centric model of a smaller company to that of a larger enterprise. In doing so, Centessa represents a new kind of pharmaceutical company that operates in a bottom-up organizational structure with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts. At its inception, Centessa consists of 10 subsidiary companies advancing a portfolio of high conviction programs with strong biological validation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Centessa PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    +1.617.468.5770
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://centessa.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/centessa/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nxera Pharma To Get $1.8M Milestone Payment From Centessa Pharma
    Nxera Pharma To Get $1.8M Milestone Payment From Centessa Pharma

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3236918/0/en/Nxera-Pharma-to-Receive-1-8-Million-Milestone-Payment-from-Centessa-Pharmaceuticals.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Centessa Pharma To Join Investor Conferences
    Centessa Pharma To Join Investor Conferences

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231009/0/en/Centessa-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Centessa Pharma Unveils Expanded Data on OX2R Agonist at ACNP
    Centessa Pharma Unveils Expanded Data on OX2R Agonist at ACNP

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3219167/0/en/Centessa-Pharmaceuticals-Announces-Poster-Presentation-of-New-Preclinical-Data-Supporting-Expansion-of-Orexin-Receptor-2-OX2R-Agonist-Pipeline-into-Neuropsychiatric-Indications-at-.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Nxera Pharma To Get Us$3.6M Milestone Payment From Centessa
    Nxera Pharma To Get Us$3.6M Milestone Payment From Centessa

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217485/0/en/Nxera-Pharma-to-Receive-US-3-6-Million-in-Milestone-Payment-Pursuant-to-Research-Collaboration-with-Centessa.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Centessa Pharma Announces CEO Change to Expand Orexin Work
    Centessa Pharma Announces CEO Change to Expand Orexin Work

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203769/0/en/Centessa-Pharmaceuticals-Announces-CEO-Transition-as-Company-Advances-Strategy-to-Extend-Orexin-Leadership-into-Multiple-Neuroscience-Indications.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Centessa Pharma Sets $250M Ads Public Offering
    Centessa Pharma Sets $250M Ads Public Offering

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3185855/0/en/Centessa-Pharmaceuticals-Announces-Pricing-of-250-000-000-Public-Offering-of-American-Depositary-Shares.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search